By contrast, infectious diseases pose potentially global threats, and the benefits of genomics for infectious disease control may therefore be felt on a global as well as a local scale. Meanwhile, richer countries appear more inclined to invest in lines of genomic research and development that orient them chiefly towards domestic matters, and that provide less incentive to collaborate internationally in research and implementation. Also, the findings represent only a snapshot of a rapidly developing field, as of summer 2012.